AIIMS Researchers Laud GST Reforms for Affordable Cancer Medicines

Entertainment National Sports Markets Business & Economy Lifestyle World Astrology & Religion Technology Education & Jobs Auto Politics Viral Opinions

Loading more articles...

GST Reforms Slash Cancer Treatment Costs, AIIMS Researchers Applaud Policy Shift

एम्स की एक स्टडी में जीएसटी रिफॉर्म से कैंसर के इलाज में फायदा होने की बात सामने आई है.

N

News18•15-02-2026, 11:24

GST Reforms Slash Cancer Treatment Costs, AIIMS Researchers Applaud Policy Shift

•Recent GST reforms aim to make cancer care more affordable and accessible, lauded by AIIMS researchers.
•56th GST Council meeting exempted 33 life-saving drugs, including cancer medications, from 12% GST.
•GST on three critical drugs for rare diseases and cancer, and on individual health/life insurance, also removed.
•GST on tobacco products increased to 40%, highest in India, to generate revenue for cancer care and prevention.
•Researchers emphasize effective implementation and monitoring for full benefits to reach patients.

Read Full Article on News18 in Hindi

✦

More like this

✦

More like this

Cancer surgery aimed to achieve maximal clearance by removing the entire tumor

Minimally Invasive Cancer Treatment: Less Surgery, Faster Recovery, Better Lives

Lung Cancer: No Longer Just a Smoker's Disease in India, Says Dr. Rajpurohit

Lung Cancer: No Longer Just a Smoker's Disease in India, Says Dr. Rajpurohit

Low Oxygen Slows Tumor Growth: Indian Researchers Uncover New Cancer Treatment Path

Low Oxygen Slows Tumor Growth: Indian Researchers Uncover New Cancer Treatment Path

NRI Health Policy Buys Soar 126%: Tech, Lower Premiums Drive Surge

NRI Health Policy Buys Soar 126%: Tech, Lower Premiums Drive Surge

एडवांस टेक्नोलॉजी, क्लीनिकल ट्रायल्स, पेटेंट कानून और कच्चे माल जैसे फैक्टर्स के कारण यूरोप और अमेरिका कैंसर की ज्यादातर दवाएं बनाते हैं.

Why India Imports Most Cancer Drugs: A Doctor Explains Key Reasons

Opening New Medical Frontiers | These discoveries have opened new medical frontiers for treating autoimmune diseases, improving cancer therapies, and preventing complications after transplantations. Regulatory T cells are often found in cancerous tumors, where they may shield the tumor from immune attack. Researchers are exploring ways to overcome this protection. Understanding FOXP3 and regulatory T cells now allows scientists to design therapies that reprogram the immune system to fight cancer or reduce autoimmunity, offering hope for more precise and effective medical interventions. Scientists are also working on genetically modified versions of T cells to promote organ transplant tolerance—the body’s ability to accept foreign tissue from a donor. (Image: Canva)

Cell and Gene Therapies Revolutionize Rare Disease Care in India